Skip to content
2000
Volume 29, Issue 42
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

For over 50 years of azapeptide synthetic techniques, developments have renewed the field of peptidomimetic therapeutics. Azapeptides are close surrogates of natural peptides: they contain a substitution of the amino acid α-carbon by a nitrogen atom. Goserelin (1989) and Atazanavir (2003) are two well-known, FDA-approved azapeptide-based drugs for the treatment of cancers and HIV infection, providing evidence for the successful clinical implementation of this class of therapeutic. This review highlights the azapeptides in recent medicinal chemistry applications and synthetic milestones. We describe the current techniques for azapeptide bond formation by introducing azapeptide coupling reagents and chain elongation methods both in solution and solid-phase strategies.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867329666220510214402
2022-12-01
2025-06-26
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867329666220510214402
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test